TEXAS – President-elect Joe Biden has said that  combating the worsening coronavirus is among his top priorities, and on Monday he named the members of his coronavirus task force.


What You Need To Know

  • Dr. Robert Rodriquez named to President-elect Joe Biden's coronavirus task force

  • Rodriques is from Brownsville, Texas

  • Currently a professor at University of California, San Francisco

  • Spent time treating coronavirus patients in Rio Grande Valley

Among them is Dr. Robert Rodriguez. Rodriquez, from Brownsville, Texas, is currently a professor of emergency medicine at the University of California, San Francisco, School of Medicine.

A graduate of Harvard Medical School, Rodriquez spent time in the Rio Grande Valley this past summer to treat coronavirus patients there as infections and hospitalizations soared.

According to Biden’s transition team, Rodriquez has authored in excess of 100 scientific papers and has led national research teams, including on topics related to coronavirus.

The other members of the task force include the following:

Dr. David Kessler, co-chair. Professor of pediatrics and epidemiology and biostatistics at the University of California, San Francisco, U.S. Food and Drug Administration commissioner from 1990 to 1997.

Dr. Vivek Murthy, co-chair. U.S. surgeon general from 2014-17, who commanded public health force that dealt with Ebola, Zika and Flint water crisis.

Dr. Marcella Nunez-Smith, co-chair. Associate professor of internal medicine, public health and management at Yale University and associate dean for health equity research at Yale’s medical school specializing in health care for marginalized populations.

Dr. Rick Bright. Immunologist, virologist. Ousted as head of the Biomedical Advanced Research and Development Authority after criticizing the federal government’s response to the coronavirus under President Donald Trump. Bright filed a whistleblower complaint alleging he was reassigned to a lesser job because he resisted political pressure to allow widespread use of hydroxychloroquine, a malaria drug Trump pushed as a COVID-19 treatment.

Dr. Luciana Borio. Vice president of technical staff at the In-Q-Tel strategic investment firm who until last year was a biodefense specialist on the National Security Council.

Dr. Ezekiel Emanuel. Oncologist and chair of the Department of Medical Ethics and Health Policy at the University of Pennsylvania who since 1997 has served as chair of the Department of Bioethics at The Clinical Center of the National Institutes of Health.

Dr. Atul Gawande. Professor of surgery at Brigham and Women’s Hospital and at Harvard Medical School who served as a senior adviser in the Department of Health and Human Services in the Clinton administration.

Dr. Celine Gounder. Clinical assistant professor at the NYU Grossman School of Medicine who served as assistant commissioner and director of the Bureau of Tuberculosis Control at New York City’s Department of Health and Mental Hygiene.

Dr. Julie Morita. Executive vice president of the Robert Wood Johnson Foundation who helped lead Chicago’s Department of Public Health for nearly 20 years.

Michael Osterholm. Director of the Center for Infectious Disease Research and Policy at the University of Minnesota, former science envoy for health security for the State Department.

Ms. Loyce Pace. Executive director and president of the Global Health Council, who previously served in leadership positions at the American Cancer Society.

Dr. Eric Goosby. Infectious disease expert and professor of medicine at the University of California, San Francisco, School of Medicine who during the Clinton administration was the founding director of the largest federally funded HIV/AIDS program.

The Associated Press contributed to this report.